|
Gene | Original role | Possible role in Parkinson’s disease | Expression level in basal ganglia based on The Human Protein Atlas | References |
|
IGFN1 | Synaptic assembly in the muscular tissue | Autophagy and protein synthesis | Low | [24–27] |
TMEM169 | Integral component of the membrane | Intracellular trafficking | High | [22, 23, 28] |
TMEM9 | Lysosomal acidification | Autophagic degradation of damaged organelles and protein aggregates | High | [22, 29–31] |
SLC13A4 | Transmembrane transporter | Specific variants may be involved in early-onset Parkinson’s disease | High | [32, 33] |
SLC39A4 | Transmembrane transporter | Specific variants may be involved in early-onset Parkinson’s disease | Low | [32, 33] |
CACNA1A | Calcium channel | Trinucleotide expansion in CACNA1A causes slowly progressive, late-onset cerebellar ataxia, and parkinsonism | High | [34, 35] |
OGDH | Krebs cycle | Its loss impairs autophagy and leads to neurodegeneration | High | [36, 37] |
TBC1D15 | Mitochondria-lysosome contact and autophagy | Impaired autophagy and mitochondria-lysosome contact | High | [38, 39] |
F13A1 | Coagulation | F13A1 was significantly associated with Alzheimer’s disease, MCI, and Parkinson’s disease, without a clear mechanism | Low | [40, 41] |
CD80 | A costimulatory molecule in T cell activation | Promoting T cell infiltration, inflammation, and neurodegeneration | Low | [42, 43] |
CBLB | Proto-oncogene | It prevents JNK-mediated neuronal death | High | [44, 45] |
FECH | Heme synthesis by adding ferrous to protoporphyrin IX | Heme can form complexes with α-synuclein, and excessive heme can cause neurodegeneration | High | [46–48] |
GAK | Regulating clathrin-coated vesicle trafficking and α-synuclein overexpression | Maybe, by regulating vesicle trafficking and α-synuclein expression | High | [49–51] |
KIF25 | A microtubule-dependent motor protein | Impaired microtubule trafficking can lead to mitochondrial dysfunction and neurodegeneration | High | [52–54] |
SAMD12 | Involved in transmembrane receptor protein tyrosine kinase signaling pathway | N/A | High | [55, 56] |
ZNF586 | Involved in protein-protein and protein-nucleic acid interaction | Maybe, involved in neurodegenerative diseases | High | [57, 58], |
CYP2A6 | Metabolizing nicotine | Accelerating neurodegeneration by removing nicotine | Low | [59–61] |
DACT3 | Inhibition of autophagy and WNT/catenin signaling pathway | Inhibiting α-synuclein removal and contributing to neurodegeneration | High | [62–65] |
GALNT8 | O-linked glycosylation | Maybe, in neurogenesis and neurodegeneration | High | [66–68] |
DLG2 | Involved in synaptic function | Maybe, accelerates motor symptoms | Moderate-to-high | [69, 70] |
GPC5 | Cell membrane proteoglycan involved in growth and cell division | Maybe, differentiation of dopaminergic neurons | High | [71] |
TRPV1 | A cell surface receptor and ion channel | α-Synuclein removal and prevention of neurodegeneration | High | [72, 73] |
GRM7 | Involved in glutamatergic neurotransmission | Improving motor dysfunction in PD | High | [74, 75] |
|